Search research articles
Contact Us
Filters
Showing results (211-220 of 323) with videos related to
Page
of 33
Sort By:
JCO Precision Oncology
|
November 10, 2022
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases
Federica Marmorino, Michele Prisciandaro, Mirella Giordano, et al.
Journal for Immunotherapy of Cancer
|
June 5, 2023
Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade
Giovanni Randon, Yu Aoki, Romain Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 11, 2024
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial
Vincenzo Nasca, Natalie Prinzi, Jorgelina Coppa, et al.
International Journal of Cancer
|
June 9, 2022
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial
Alessandra Raimondi, Giovanni Randon, Michele Prisciandaro, et al.
Nature Communications
|
December 9, 2016
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
Beth O Van Emburgh, Sabrina Arena, Giulia Siravegna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2025
CtDNA detection with low-pass whole genome bisulfite sequencing in RAS wild-type metastatic colorectal cancer: an exploratory objective of the VALENTINO trial
Paolo Manca, Marta Paoli, Francesca Galardi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 21, 2025
Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors
Claire Gallois, Margherita Ambrosini, Sara Lonardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 9, 2015
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer
Filippo Pietrantonio, Giuseppe Aprile, Lorenza Rimassa, et al.
Nature Communications
|
March 25, 2026
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial
Angela Damato, Riziero Esposito Abate, Simona Tessitore, et al.
The New England Journal of Medicine
|
June 1, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
Eileen M O'Reilly, Zev A Wainberg, Andrew E Hendifar, et al.
Page
of 33
Search research articles
Search
Showing results (211-220 of 323) with videos related to
Sort By:
Page
of 33
JCO Precision Oncology
|
November 10, 2022
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases
Federica Marmorino, Michele Prisciandaro, Mirella Giordano, et al.
Journal for Immunotherapy of Cancer
|
June 5, 2023
Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade
Giovanni Randon, Yu Aoki, Romain Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 11, 2024
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial
Vincenzo Nasca, Natalie Prinzi, Jorgelina Coppa, et al.
International Journal of Cancer
|
June 9, 2022
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial
Alessandra Raimondi, Giovanni Randon, Michele Prisciandaro, et al.
Nature Communications
|
December 9, 2016
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
Beth O Van Emburgh, Sabrina Arena, Giulia Siravegna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2025
CtDNA detection with low-pass whole genome bisulfite sequencing in RAS wild-type metastatic colorectal cancer: an exploratory objective of the VALENTINO trial
Paolo Manca, Marta Paoli, Francesca Galardi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 21, 2025
Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors
Claire Gallois, Margherita Ambrosini, Sara Lonardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 9, 2015
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer
Filippo Pietrantonio, Giuseppe Aprile, Lorenza Rimassa, et al.
Nature Communications
|
March 25, 2026
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial
Angela Damato, Riziero Esposito Abate, Simona Tessitore, et al.
The New England Journal of Medicine
|
June 1, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
Eileen M O'Reilly, Zev A Wainberg, Andrew E Hendifar, et al.
Page
of 33